Copyright
©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1817-1829
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1817
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1817
Variable | Adjusted odds ratio | 95%CI | P value |
Age | 1.02 | 1.00-1.04 | < 0.001 |
Median income in patient zip code | |||
$1-$38999 | Reference | ||
$39000-$47999 | 1.07 | 0.98-1.16 | 0.117 |
$48000-$62999 | 0.99 | 0.9-1.08 | 0.983 |
> $63000 | 0.95 | 0.85-1.02 | 0.141 |
Female sex | 1.07 | 1.00-1.14 | 0.023 |
Race | |||
Caucasian | Reference | ||
African Americans | 0.81 | 0.72-0.9 | < 0.001 |
Hispanic | 0.71 | 0.64-0.78 | < 0.001 |
Others | 0.89 | 0.78-1.00 | 0.069 |
Charleson comorbidity index | 1.1 | 1.08-1.12 | < 0.001 |
Insurance status | |||
Medicare | Reference | ||
Medicaid | 1.34 | 1.19-1.51 | < 0.001 |
Private insurance | 1.18 | 1.08-1.29 | < 0.001 |
Uninsured | 1.52 | 1.36-1.7 | < 0.001 |
Teaching hospital | 1.4 | 1.28-1.53 | < 0.001 |
Bed size | |||
< 250 beds | Reference | ||
251-400 beds | 1.24 | 1.09-1.42 | 0.001 |
> 400 Beds | 1.25 | 1.1-1.41 | < 0.001 |
Urban location | 0.96 | 0.83-1.19 | 0.625 |
Length of stay by groups | |||
< 3 d | Reference | ||
3-5 d | 0.92 | 0.84-1.00 | 0.065 |
> 5 d | 1.18 | 1.10-1.26 | < 0.001 |
Rehab transfer | 4.07 | 3.29-5.04 | < 0.001 |
ACLF Score | |||
1 | 2.53 | 2.35-2.71 | < 0.001 |
2 | 6.05 | 5.5-6.66 | < 0.001 |
3 | 9.86 | 8.75-11.1 | < 0.001 |
4 | 10.61 | 7.32-15.42 | < 0.001 |
ACLF ≥ 2 | 3.47 | 3.21-3.74 | < 0.001 |
Hepatocellular carcinoma | 1.78 | 1.58-2.00 | < 0.001 |
Infection | 1.58 | 1.48-1.69 | < 0.001 |
Mechanical ventilation | 3.32 | 3.1-3.54 | < 0.001 |
Total parenteral nutrition | 2.02 | 1.8-2.27 | < 0.001 |
Hepatorenal syndrome | 3.4 | 3.04-3.81 | < 0.001 |
Ascites | 1.13 | 1.03-1.24 | < 0.001 |
Spontaneous bacterial peritonitis | 3.34 | 2.65-3.86 | < 0.001 |
Age | 1.02 | 1.00-1.04 | < 0.001 |
Female sex | 1.07 | 1.00-1.14 | 0.023 |
Race | |||
Caucasian | Reference | ||
African Americans | 0.81 | 0.72-0.9 | < 0.001 |
Hispanic | 0.71 | 0.64-0.78 | < 0.001 |
Others | 0.89 | 0.78-1.00 | 0.069 |
Charleson comorbidity index | 1.1 | 1.08-1.12 | < 0.001 |
Insurance status | |||
Medicare | Reference | ||
Medicaid | 1.34 | 1.19-1.51 | < 0.001 |
Private insurance | 1.18 | 1.08-1.29 | < 0.001 |
Uninsured | 1.52 | 1.36-1.7 | < 0.001 |
Teaching hospital | 1.4 | 1.28-1.53 | < 0.001 |
Bed size | |||
< 250 beds | Reference | ||
251-400 beds | 1.24 | 1.09-1.42 | 0.001 |
> 400 Beds | 1.25 | 1.1-1.41 | < 0.001 |
Urban location | 0.96 | 0.83-1.19 | 0.625 |
Length of stay by groups | |||
< 3 d | Reference | ||
3-5 d | 0.92 | 0.84-1.00 | 0.065 |
> 5 d | 1.18 | 1.10-1.26 | < 0.001 |
Rehab transfer | 4.07 | 3.29-5.04 | < 0.001 |
ACLF ≥ 2 | 3.47 | 3.21-3.74 | < 0.001 |
- Citation: Gupta K, Hans B, Khan A, Sohail SH, Kapuria D, Chang C. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol 2022; 14(9): 1817-1829
- URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1817.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1817